Home Tags Exelixis

Tag: Exelixis

Have Investors Given Up On Exelixis, Inc. (EXEL), Hope Bancorp, Inc....

Jan 17 was a weak volume day for Exelixis, Inc. (NASDAQ:EXEL), with a downside momentum. The trading capacity for the firm moved to 4319123...

Hedge Funds Now Own 79.4% Of Exelixis, Inc. (EXEL)

Exelixis, Inc. (NASDAQ:EXEL) has made a 70.34% comeback from a 12-month low price of $13.42. It was seen -3.79% lower, changing the price to...

Exelixis, Inc. (EXEL), Tesla, Inc. (TSLA) in Focus on Mixed Analyst...

Exelixis, Inc. (NASDAQ:EXEL) recent rally took place on significantly more volume which surged nearly 4336699 contracts on 07-Jan-19 versus its daily average of 4186800....

A Likely Value Trap For Investors: Exelixis, Inc. (EXEL), Anadarko Petroleum...

Exelixis, Inc. (NASDAQ:EXEL) current P/S is an impressive 23.64. The overall Biotechnology: Commercial Physical & Biological Resarch group has an average P/S ratio of...

Is There A Rising Institutional Investor Interest in Exelixis, Inc. (EXEL)?

Exelixis, Inc. (NASDAQ:EXEL) marched up 46.05% compared to a 52-week low price of $13.42. The shares were last seen trading -1.66% lower, taking the...

Guru Stock Analysis: Exelixis, Inc. (EXEL), Real Goods Solar, Inc. (RGSE)

Heading into the close, a volume-light day saw Exelixis, Inc. (NASDAQ:EXEL) moving up $0.65 from the opening price. The volume for the company on...

A Likely Value Trap For Investors: Exelixis, Inc. (EXEL), VMware, Inc....

Exelixis, Inc. (NASDAQ:EXEL) current P/S is an impressive 23.64. The overall Biotechnology: Commercial Physical & Biological Resarch group has an average P/S ratio of...

Can The Momentum Keep Going For Exelixis, Inc. (EXEL), TOTAL S.A....

Exelixis, Inc. (NASDAQ:EXEL) last session’s volume of 3.14 million shares was lower than its average volume of 4.17 million shares. The stock, after opening...

Exelixis, Inc. (EXEL): No Bullish Case For This Stock Right Now?

Exelixis, Inc. (NASDAQ:EXEL) has made a 43.52% comeback from a 12-month low price of $13.42. It was seen 1.64% higher, changing the price to...

Potential Opportunity To Buy or Exit? – Exelixis, Inc. (EXEL), Analog...

Exelixis, Inc. (NASDAQ:EXEL) is simply too cheap to pass with a price-to-sales ratio of 7.56. The competitors from Biotechnology: Commercial Physical & Biological Resarch...